<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753424</url>
  </required_header>
  <id_info>
    <org_study_id>semiTmeniscus</org_study_id>
    <nct_id>NCT04753424</nct_id>
  </id_info>
  <brief_title>Semitendinosus Graft as Meniscal Transplant</brief_title>
  <official_title>Autologous Semitendinosus Tendon Graft as Meniscal Transplant - a Clinical Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Removal of meniscal tissue is described to result in poor knee function and a significant&#xD;
      risk for future development of osteoarthritis. Different implants have been suggested to&#xD;
      substitute a removed meniscus. Meniscal allograft transplantation is not widely available due&#xD;
      to costs and availability. The semitendinosus tendon is a known graft with biological&#xD;
      properties with potential to remodel and revascularize in an intraarticular environment such&#xD;
      as anterior cruciate ligament reconstruction. The objective for this study was to investigate&#xD;
      whether the semitendinosus tendon graft could function as a meniscal transplant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Failure</measure>
    <time_frame>2 years</time_frame>
    <description>Surgical failure of transplant defined as meniscus symptoms (joint line tenderness, swelling, locking or positive McMurray) resulting in a need for re-arthroscopy and subtotal or total resection of the transplant.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved subjective knee function</measure>
    <time_frame>2 years</time_frame>
    <description>Patient reported outcome measure using the Knee Injury and Osteoarthritis Outcome Score (KOOS), 0-100 where 100 indicate best possible result.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved subjective knee function</measure>
    <time_frame>2 years</time_frame>
    <description>Patient reported outcome measure using Lysholm (0-100 where 100 indicate best possible result) and Tegner activity score (0-10, where 10 indicate the highest activity level) .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved subjective knee function</measure>
    <time_frame>2 years</time_frame>
    <description>Patient reported outcome measure using Euroqol 5 dimensions (EQ-5D) score (quality of life instrument with five dimensions with points from 1 to 3 where 1 indicates no problem and 3 indicate severe problems).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved subjective knee function</measure>
    <time_frame>2 years</time_frame>
    <description>Patient reported outcome measure using Global score (0-10 where 10 indicate best possible result)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Patient Satisfaction</condition>
  <condition>Graft Failure</condition>
  <condition>Osteo Arthritis Knee</condition>
  <condition>ACL</condition>
  <condition>Meniscus Tear</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical technique</intervention_name>
    <description>Description of novel surgical technique using autologous semitendinosus graft as meniscus transplant.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients, both male and female, 20-50 years of age, with previous subtotal or total&#xD;
        meniscectomy, suffering from post meniscectomy symptoms are assessed at the outpatient&#xD;
        clinic. If inclusion criteria are met, the patients receive information regarding the&#xD;
        treatment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Previous subtotal or total meniscectomy&#xD;
&#xD;
          -  Post meniscectomy symptoms&#xD;
&#xD;
          -  No osteoarthritic changes on radiography more than Ahlbäck 1&#xD;
&#xD;
          -  Knee aligment (hip-knee-angle) +/- 3°&#xD;
&#xD;
          -  No persisting ACL insufficiency&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Difficulty understanding the instructions&#xD;
&#xD;
          -  Current psychiatric diagnosis&#xD;
&#xD;
          -  Smoking&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karl Eriksson, Assoc.Prof</last_name>
    <phone>0046707202646</phone>
    <email>karl.eriksson@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erik Rönnblad, MD</last_name>
    <phone>0046736785549</phone>
    <email>erik.ronnblad@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KISÖS</name>
      <address>
        <city>Stockholm</city>
        <zip>11883</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Eriksson, Assoc.prof</last_name>
      <phone>0046707202646</phone>
      <email>karl.eriksson@ki.se</email>
    </contact>
    <contact_backup>
      <last_name>Erik Ronnblad, MD</last_name>
      <phone>0046736785549</phone>
      <email>erik.ronnblad@ki.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Kohn D. Autograft meniscus replacement: experimental and clinical results. Knee Surg Sports Traumatol Arthrosc. 1993;1(2):123-5.</citation>
    <PMID>8536007</PMID>
  </reference>
  <reference>
    <citation>Johnson LL, Feagin JA Jr. Autogenous tendon graft substitution for absent knee joint meniscus: a pilot study. Arthroscopy. 2000 Mar;16(2):191-6.</citation>
    <PMID>10705332</PMID>
  </reference>
  <reference>
    <citation>Ayala Mejias JD, Sciamanna RC, Muniesa MP, Pérez-España LA. A case report of semitendinosus tendon autograft for reconstruction of the meniscal wall supporting a collagen implant. BMC Sports Sci Med Rehabil. 2013 Mar 28;5:4. doi: 10.1186/2052-1847-5-4.</citation>
    <PMID>23557091</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>February 14, 2021</last_update_submitted>
  <last_update_submitted_qc>February 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Karl O. Eriksson</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>meniscus transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 10, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/24/NCT04753424/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

